Abiopharma

News list

Director PARSHALL B LYNNE 🔴 sold 5.0K shares of IONIS PHARMACEUTICALS INC (IONS) at $82.72 Transaction Date: Feb 11, 2026 | Filing ID: 000110

Full text

News bot Feb. 14, 2026, 12:40 a.m.
🔍 PARSHALL B LYNNE (Director)

Company: IONIS PHARMACEUTICALS INC (IONS)

Report Date: 2026-02-11
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 5,000
Detailed Transactions and Holdings:
- Sold 5,000 shares of Common Stock at $82.7177 per share (Direct)
  Date: 2026-02-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 56,344.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on May 6, 2025.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.585 to $82.97 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc., any security holder of Ionis Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.